219 related articles for article (PubMed ID: 28248800)
41. The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases.
Kattah NH; Kattah MG; Utz PJ
Immunol Rev; 2010 Jan; 233(1):126-45. PubMed ID: 20192997
[TBL] [Abstract][Full Text] [Related]
42. Long-term follow-up of 46 patients with anti-(U1)snRNP antibodies.
van den Hoogen FH; Spronk PE; Boerbooms AM; Bootsma H; de Rooij DJ; Kallenberg CG; van de Putte LB
Br J Rheumatol; 1994 Dec; 33(12):1117-20. PubMed ID: 8000737
[TBL] [Abstract][Full Text] [Related]
43. Mixed connective tissue disease.
Venables PJ
Lupus; 2006; 15(3):132-7. PubMed ID: 16634365
[TBL] [Abstract][Full Text] [Related]
44. Mixed connective tissue disease: still crazy after all these years.
Swanton J; Isenberg D
Rheum Dis Clin North Am; 2005 Aug; 31(3):421-36, v. PubMed ID: 16084316
[TBL] [Abstract][Full Text] [Related]
45. [Undifferentiated, overlapping and mixed connective tissue diseases].
Ruiz Pombo M; Labrador Horrillo M; Selva O'Callaghan A
Med Clin (Barc); 2004 Nov; 123(18):712-7. PubMed ID: 15563821
[TBL] [Abstract][Full Text] [Related]
46. Mixed connective tissue disease--goodbye to all that.
Black C; Isenberg DA
Br J Rheumatol; 1992 Oct; 31(10):695-700. PubMed ID: 1393377
[TBL] [Abstract][Full Text] [Related]
47. A new conformational epitope generated by the binding of recombinant 70-kd protein and U1 RNA to anti-U1 RNP autoantibodies in sera from patients with mixed connective tissue disease.
Murakami A; Kojima K; Ohya K; Imamura K; Takasaki Y
Arthritis Rheum; 2002 Dec; 46(12):3273-82. PubMed ID: 12483732
[TBL] [Abstract][Full Text] [Related]
48. Apoptotic modifications affect the autoreactivity of the U1 snRNP autoantigen.
Hof D; Raats JM; Pruijn GJ
Autoimmun Rev; 2005 Jul; 4(6):380-8. PubMed ID: 16081029
[TBL] [Abstract][Full Text] [Related]
49. Pregnancy outcomes in mixed connective tissue disease: a multicentre study.
Radin M; Schreiber K; Cuadrado MJ; Cecchi I; Andreoli L; Franceschini F; Caleiro T; Andrade D; Gibbone E; Khamashta M; Buyon J; Izmirly P; Aguirre MA; Benedetto C; Roccatello D; Marozio L; Sciascia S
Rheumatology (Oxford); 2019 Nov; 58(11):2000-2008. PubMed ID: 31079145
[TBL] [Abstract][Full Text] [Related]
50. Muscle involvement in mixed connective tissue disease.
Hall S; Hanrahan P
Rheum Dis Clin North Am; 2005 Aug; 31(3):509-17, vii. PubMed ID: 16084322
[TBL] [Abstract][Full Text] [Related]
51. Induction of anti-RA33 hnRNP autoantibodies and transient spread to U1-A snRNP complex of spliceosome by idiotypic manipulation with anti-RA33 antibody preparation in mice.
Steiner G; Shovman O; Skriner K; Gilburd B; Langevitz P; Miholits M; Hoet R; Levy Y; Zandman-Goddard G; Hoefler E; Smolen JS; Shoenfeld Y
Clin Exp Rheumatol; 2002; 20(4):517-24. PubMed ID: 12180437
[TBL] [Abstract][Full Text] [Related]
52. The prognosis of mixed connective tissue disease.
Lundberg IE
Rheum Dis Clin North Am; 2005 Aug; 31(3):535-47, vii-viii. PubMed ID: 16084324
[TBL] [Abstract][Full Text] [Related]
53. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.
Lundberg I; Hedfors E
J Rheumatol; 1991 Oct; 18(10):1511-9. PubMed ID: 1765975
[TBL] [Abstract][Full Text] [Related]
54. Sjögren's syndrome and mixed connective tissue disease.
Ohtsuka E; Nonaka S; Shingu M; Yasuda M; Nobunaga M
Clin Exp Rheumatol; 1992; 10(4):339-44. PubMed ID: 1395218
[TBL] [Abstract][Full Text] [Related]
55. Pulmonary hypertension not a major feature of early mixed connective tissue disease: a prospective clinicoserological study.
Haroon N; Nisha RS; Chandran V; Bharadwaj A
J Postgrad Med; 2005; 51(2):104-7, discussion 107-8. PubMed ID: 16006700
[TBL] [Abstract][Full Text] [Related]
56. Interstitial lung disease in patients with mixed connective tissue disease: pilot study on predictors of lung involvement.
Narula N; Narula T; Mira-Avendano I; Wang B; Abril A
Clin Exp Rheumatol; 2018; 36(4):648-651. PubMed ID: 29745875
[TBL] [Abstract][Full Text] [Related]
57. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G
J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064
[TBL] [Abstract][Full Text] [Related]
58. The diagnosis and classification of mixed connective tissue disease.
Tani C; Carli L; Vagnani S; Talarico R; Baldini C; Mosca M; Bombardieri S
J Autoimmun; 2014; 48-49():46-9. PubMed ID: 24461387
[TBL] [Abstract][Full Text] [Related]
59. Detection and epitope analysis of autoantigen-reactive T cells to the U1-small nuclear ribonucleoprotein A protein in autoimmune disease patients.
Okubo M; Yamamoto K; Kato T; Matsuura N; Nishimaki T; Kasukawa R; Ito K; Mizushima Y; Nishioka K
J Immunol; 1993 Jul; 151(2):1108-15. PubMed ID: 7687615
[TBL] [Abstract][Full Text] [Related]
60. Sicca symptoms and anti-SSA/Ro antibodies are common in mixed connective tissue disease.
Setty YN; Pittman CB; Mahale AS; Greidinger EL; Hoffman RW
J Rheumatol; 2002 Mar; 29(3):487-9. PubMed ID: 11908561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
